V. R. Punithavathi

668 citations
7 papers · 538 indexed · h-index 7
Topics
Natural Antidiabetic Agents Studies (3 papers)Curcumin's Biomedical Applications (2 papers)Advanced Glycation End Products research (2 papers)
Partner nations
India

In The Last Decade

V. R. Punithavathi

7 papers receiving 517 citations

Peers

V. R. Punithavathi
Comparison fields: 5 of 84
  • Endocrinology, Diabetes and Metabolism 194
  • Molecular Biology 140
  • Biochemistry 131
  • Complementary and alternative medicine 80
  • Pathology and Forensic Medicine 70
Replace Sanaa M. Abd El‐Twab with:
Sanaa M. Abd El‐Twab Egypt
N.C. Varadacharyulu India
Limin Xiang China
Gyo‐Nam Kim South Korea
Liang-Yi Wu Taiwan
Valérie B. Schini-Kerth France
Isabel Cordero‐Herrera Spain
Poovathumkal James Antony Brazil
Lixia Song China
KK Pillai India
V. R. Punithavathi relative to Sanaa M. Abd El‐Twab Egypt Sanaa M. Abd El‐Twab's profile →
Citations per field
00.5×
Sanaa M. Abd El‐Twab · 1×
Citations per year

Countries citing papers authored by V. R. Punithavathi

Since Specialization
Citations

This map shows the geographic impact of V. R. Punithavathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. R. Punithavathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. R. Punithavathi more than expected).

Fields of papers citing papers by V. R. Punithavathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. R. Punithavathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. R. Punithavathi. The network helps show where V. R. Punithavathi may publish in the future.

Co-authorship network of co-authors of V. R. Punithavathi

This figure shows the co-authorship network connecting the top 25 collaborators of V. R. Punithavathi. A scholar is included among the top collaborators of V. R. Punithavathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. R. Punithavathi. V. R. Punithavathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 62
2 18
3 40
4 221
5 43
6 49
7 105

About V. R. Punithavathi

V. R. Punithavathi is a scholar working on Biochemistry, Molecular Medicine and Clinical Biochemistry, having authored 7 papers that have together received 538 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (3 papers), Curcumin's Biomedical Applications (2 papers) and Advanced Glycation End Products research (2 papers). The work is most often cited by research in Biochemistry (131 citations), Endocrinology, Diabetes and Metabolism (194 citations) and Complementary and alternative medicine (80 citations). V. R. Punithavathi has collaborated with scholars based in India. Frequent co-authors include P. Stanely Mainzen Prince and Ramesh Kumar. Their work appears in journals such as Life Sciences, European Journal of Pharmacology and Chemico-Biological Interactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026